1. ScholarBank@NUS

Seng Gee Lim

rp00481

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Seng Gee Lim
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
Faculty
 
Email
mdclimsg@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 1-20 of 120 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12006A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BLim, S.G. ; Ng, T.M.; Guan, R.; Kung, N.; Krastev, Z.; Volfova, M.; Husa, P.; Lee, S.S.; Chan, S.; Shiffman, M.L.; Washington, M.K.; Rigney, A.; Anderson, J.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
2Jun-2008A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)Lee, Y.-M. ; Sutedja, D.S.; Wai, C.-T. ; Dan, Y.-Y. ; Aung, M.-O. ; Zhou, L. ; Cheng, C.-L.; Wee, A.; Lim, S.-G. 
32006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E. ; Bowden, S.; Locarnini, S.; Ishaque, S.M.
42006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E.; Bowden, S.; Locarnini, S.; Ishaque, S.M.
52004Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplantWai, C.-T.; Prabhakaran, K. ; Wee, A. ; Lee, Y.-M.; Dan, Y.-Y.; Sutedja, D.S.; Mak, K.; Isaac, J. ; Lee, K.-H. ; Lee, H.-L.; Da, Costa M. ; Lim, S.-G. 
62003Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BHadziyannis, S.J.; Tassopoulos, N.C.; Heathcote, E.J.; Chang, T.-T.; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S.G. ; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
72003Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BMarcellin, P.; Chang, T.-T.; Lim, S.G. ; Tong, M.J.; Sievert, W.; Shiffman, M.L.; Jeffers, L.; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
8Aug-2007Age in Guiding Strategy in Hepatitis A VaccinationWai, C.-T. ; Mak, B.; Aung, M.O. ; Lim, S.-G. 
92003An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1Tan, Y.-J.; Lim, S.-P.; Ting, A.E.; Goh, P.-Y.; Tan, Y.H.; Lim, S.G. ; Hong, W.
102007Applicability of cost-effectiveness analysis to management of chronic hepatitis BDan, Y.Y.; Lim, S.G. 
112006Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Cheng, Y. ; Seet, B.L.; Ong, C.S.L.; Wasser, S. ; Lim, S.G. ; Tan, T.M.C. ; Peter, F.J. 
12Jul-2009Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BZeuzem, S.; Gane, E.; Liaw, Y.-F.; Lim, S.G. ; DiBisceglie, A.; Buti, M.; Chutaputti, A.; Rasenack, J.; Hou, J.; O'Brien, C.; Nguyen, T.T.; Jia, J.; Poynard, T.; Belanger, B.; Bao, W.; Naoumov, N.V.
132005Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 yearLee, Y.-M. ; Wai, C.-T. ; Da, Costa M. ; Lee, K.-H. ; Sutedja, D.; Tan, K.-C.; Isaac, J. ; Lim, S.-G. 
142003CD81 engineered with endocytotic signals mediates HCV cell entry: Implications for receptor usage by HCV in vivoTan, Y.-J.; Lim, S.-P.; Goh, P.-Y.; Lim, S.G. ; Tan, Y.H.; Hong, W. ; Ng, P.
152004Cellular RNA Helicase p68 Relocalization and Interaction with the Hepatitis C Virus (HCV) NS5B Protein and the Potential Role of p68 in HCV RNA ReplicationGoh, P.-Y.; Tan, Y.-J.; Lim, S.P.; Tan, Y.H. ; Lim, S.G. ; Hong, W. ; Fuller-Pace, F.
16Jul-2004Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirusFielding, B.C.; Tan, Y.-J. ; Shuo, S. ; Tan, T.H.P.; Ooi, E.-E. ; Lim, S.G. ; Hong, W. ; Goh, P.-Y. 
172004Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirusFielding, B.C.; Tan, Y.-J.; Shuo, S.; Tan, T.H.P.; Lim, S.G. ; Hong, W. ; Goh, P.-Y.; Ooi, E.-E.
182008Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BLim, S.G. ; Leung, N.; Hann, H.W.L.; Lau, G.K.K.; Trepo, C.; Mommeja-Marin, H.; Moxham, C.; Sorbel, J.; Snow, A.; Blum, M.R.; Rousseau, F.; Marcellin, P.
192007Clinical trial: Effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis BLim, S.G. ; Marcellin, P.; Tassopoulos, N.; Hadziyannis, S.; Chang, T.T.; Tong, M.; Sievert, W.; Hu, P.; Arterburn, S.; Brosgart, C.L.
202002Delayed tacrolimus is safe with basiliximab induction therapyLee, K.H. ; Da Costa, M.; Lim, S.-G. ; Tan, K.-C.